Redwood Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Redwood Investments's BMY Position: Q1 2019 in Review
Redwood Investments sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 185,492 shares — an estimated $9.64M sold.
Redwood Investments first reported a position in BMY in Q1 2016 and held it in 7 quarters. The position peaked at $23.4M in Q2 2016. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.
- Redwood Investments reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
- Redwood Investments sold 185,492 Bristol-Myers Squibb shares in Q1 2019, an estimated $9.64M.
- Redwood Investments first reported a position in Bristol-Myers Squibb in Q1 2016 and held it in 7 quarters.
- Redwood Investments's Bristol-Myers Squibb position peaked at $23.4M in Q2 2016.
- 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.
Based on Redwood Investments's 13F filing for Q1 2019, filed 7 May 2019.